CERC Cerecor Inc.

5.18
+0.1  (+2%)
Previous Close 5.08
Open 5.2
Price To Book 10.79
Market Cap 211365699
Shares 40,804,189
Volume 67,824
Short Ratio
Av. Daily Volume 90,658

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 top-line data released December 5, 2016 - endpoint not met.
CERC-501
Smoking cessation
Phase 2 top-line data released November 29, 2016 failed to meet primary endpoint.
CERC-301
Major depressive disorder (MDD)
Phase 1 data due 1H 2019.
CERC-301
Neurogenic Orthostatic Hypotension (nOH)

SEC Filings

  1. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19607927
  2. EFFECT - Notice of Effectiveness 19587476
  3. 424B3 - Prospectus [Rule 424(b)(3)] 19585849
  4. 8-K - Current report 19532281
  5. S-3 - Registration statement under Securities Act of 1933 19531084
  6. SC 13D/A [Amend] - General statement of acquisition of beneficial ownership 181260433
  7. 8-K - Current report 181254881
  8. 8-K/A [Amend] - Current report 181215190
  9. 8-K - Current report 181202532
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 181175306